• Publications
  • Influence
Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children.
Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children Paul S. Thornton, MB, BCh, Charles A. Stanley, MD,Expand
  • 204
  • 14
  • PDF
Re-evaluating "transitional neonatal hypoglycemia": mechanism and implications for management.
A Committee of the Pediatric Endocrine Society was recently asked by xxx to develop guidelines for evaluation and management of hypoglycemia in neonates, infants, and children. To aid in formulatingExpand
  • 100
  • 8
  • PDF
Intrauterine growth restriction decreases pulmonary alveolar and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro in fetal sheep.
Intrauterine growth restriction (IUGR) increases the risk for bronchopulmonary dysplasia (BPD). Abnormal lung structure has been noted in animal models of IUGR, but whether IUGR adversely impactsExpand
  • 138
  • 7
  • PDF
Attenuated insulin release and storage in fetal sheep pancreatic islets with intrauterine growth restriction.
We determined in vivo and in vitro pancreatic islet insulin secretion and glucose metabolism in fetuses with intrauterine growth restriction (IUGR) caused by chronic placental insufficiency toExpand
  • 173
  • 7
Increased insulin sensitivity and maintenance of glucose utilization rates in fetal sheep with placental insufficiency and intrauterine growth restriction.
In this study we determined body weight-specific fetal (umbilical) glucose uptake (UGU), utilization (GUR), and production rates (GPR) and insulin action in intrauterine growth-restricted (IUGR)Expand
  • 143
  • 7
  • PDF
Hypoglycemia in Newborn Infants: Features Associated with Adverse Outcomes
The purpose of this review article is to document from the literature values of blood/plasma glucose concentration and associated clinical signs and conditions in newborn infants (both term andExpand
  • 171
  • 4
The intrauterine growth restriction phenotype: fetal adaptations and potential implications for later life insulin resistance and diabetes.
The intrauterine growth restricted (IUGR) fetus develops unique metabolic adaptations in response to exposure to reduced nutrient supply. These adaptations provide survival value for the fetus byExpand
  • 90
  • 4
Maternal amino acid supplementation for intrauterine growth restriction.
Maternal dietary protein supplementation to improve fetal growth has been considered as an option to prevent or treat intrauterine growth restriction. However, in contrast to balanced dietaryExpand
  • 61
  • 4
  • PDF
Increased Hepatic Glucose Production in Fetal Sheep With Intrauterine Growth Restriction Is Not Suppressed by Insulin
Intrauterine growth restriction (IUGR) increases the risk for metabolic disease and diabetes, although the developmental origins of this remain unclear. We measured glucose metabolism during basalExpand
  • 55
  • 4
  • PDF
Consequences of a compromised intrauterine environment on islet function.
Low birth weight is an important risk factor for impaired glucose tolerance and diabetes later in life. One hypothesis is that fetal beta-cells inherit a persistent defect as a developmental responseExpand
  • 86
  • 3
  • PDF